These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32472659)

  • 1. Management of periorbital hyperpigmentation: An overview of nature-based agents and alternative approaches.
    Sawant O; Khan T
    Dermatol Ther; 2020 Jul; 33(4):e13717. PubMed ID: 32472659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Periorbital Vascularity, Erythema, and Hyperpigmentation.
    Samaan CB; Cartee TV
    Clin Plast Surg; 2023 Jul; 50(3):399-409. PubMed ID: 37169406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments of Periorbital Hyperpigmentation: A Systematic Review.
    Michelle L; Pouldar Foulad D; Ekelem C; Saedi N; Mesinkovska NA
    Dermatol Surg; 2021 Jan; 47(1):70-74. PubMed ID: 32740208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Periorbital Vascularity, Erythema, and Hyperpigmentation.
    Samaan CB; Cartee TV
    Facial Plast Surg Clin North Am; 2022 Aug; 30(3):309-319. PubMed ID: 35934433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment.
    Roberts WE
    J Drugs Dermatol; 2014 Apr; 13(4):472-82. PubMed ID: 24719068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferulic acid 12% peel: An innovative peel for constitutional type of periorbital melanosis-Comparing clinical efficacy and safety with 20% glycolic peel and 15% lactic peel.
    Dayal S; Sangal B; Sahu P
    J Cosmet Dermatol; 2020 Sep; 19(9):2342-2348. PubMed ID: 31944519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periorbital Hyperpigmentation: A Comprehensive Review.
    Sarkar R; Ranjan R; Garg S; Garg VK; Sonthalia S; Bansal S
    J Clin Aesthet Dermatol; 2016 Jan; 9(1):49-55. PubMed ID: 26962392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carboxytherapy and platelet-rich plasma in treatment of periorbital hyperpigmentation: A comparative clinical trial.
    Nofal E; Elkot R; Nofal A; Eldesoky F; Shehata S; Sami M
    J Cosmet Dermatol; 2018 Dec; 17(6):1000-1007. PubMed ID: 29297970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
    Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
    J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and characteristics of periorbital hyperpigmentation.
    Fatin AM; Mathana Sundram TK; Tan SSE; Seghayat MS; Lee CK; Rehman N; Tan CK
    Skin Res Technol; 2020 Jul; 26(4):564-570. PubMed ID: 31916334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification.
    Ranu H; Thng S; Goh BK; Burger A; Goh CL
    Dermatol Surg; 2011 Sep; 37(9):1297-303. PubMed ID: 21682796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Carboxytherapy versus Combined Microneedling with Topical Glutathione in the Treatment of Patients with Periorbital Hyperpigmentation: An Evaluator-Blind, Split-Face, Controlled Pilot Clinical Trial.
    Assaf HA; Ahmed D; Abdelhamed A
    Indian J Dermatol; 2022; 67(5):504-511. PubMed ID: 36865870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles.
    Vavouli C; Katsambas A; Gregoriou S; Teodor A; Salavastru C; Alexandru A; Kontochristopoulos G
    J Cosmet Dermatol; 2013 Sep; 12(3):204-9. PubMed ID: 23992162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of using platelet-rich plasma versus chemical peeling in periorbital hyperpigmentation.
    Ellabban NF; Eyada M; Nada H; Kamel N
    J Cosmet Dermatol; 2019 Dec; 18(6):1680-1685. PubMed ID: 31021041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of 20% glycolic peel, 15% lactic peel, and topical 20% vitamin C in constitutional type of periorbital melanosis: a comparative study.
    Dayal S; Sahu P; Jain VK; Khetri S
    J Cosmet Dermatol; 2016 Dec; 15(4):367-373. PubMed ID: 27380862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients.
    Stratigos AJ; Katsambas AD
    Am J Clin Dermatol; 2004; 5(3):161-8. PubMed ID: 15186195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosystems with potential application as carriers for skin depigmenting actives.
    Castro NR; Pinto CDSC; Dos Santos EP; Mansur CRE
    Nanotechnology; 2024 Jul; 35(40):. PubMed ID: 38901412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.